首页> 外文期刊>Urology >Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer.
【24h】

Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer.

机译:单灶,单侧,切缘阴性和小体积前列腺癌的术前预测。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Contemporary prostate carcinoma is frequently of small volume and early stage. Subtotal gland ablation by minimally invasive therapies such as cryotherapy demands preoperative prediction of unifocal, unilateral, margin-negative, and small volume (less than 0.5 mL) cancer. METHODS: We examined matched biopsy and prostatectomy and clinical data from 393 patients at two institutions who underwent surgery in 2000 through 2003. Radical prostatectomy specimens were uniformly sectioned at 5-mm intervals and completely embedded. Numerous clinical and biopsy variables were correlated by regression analysis with unifocal, unilateral, margin-negative, and 0.5 mL or less volume cancer in the prostatectomy specimen. Odds ratios (OR) were determined. RESULTS: At prostatectomy, 92 (23%) had unifocal cancer, 90 (23%) had unilateral cancer, 348 (89%) had organ-confined cancer, and 106 (31%) had small volume cancer. Unilateral cancer occurred in 71% to 76% of cases of unilateral cancer in the biopsy (OR, 4.30; if 9 or more cores were sampled, OR rose to 6.83), and was predicted by unifocality in the biopsy (OR, 2.63). Unifocal cancer was predicted by unilateral (OR, 2.66) but not unifocal, cancer present in the biopsy. Negative surgical margins were predicted by unilateral (OR, 2.53; positive predictive value, 82%) cancer in the biopsy and by serum prostate specific antigen (OR, 5.33). Small volume cancer was predicted by unilateral (OR, 5.50) and unifocal (OR, 7.98) cancer in the biopsy; Gleason score greater than 7 predicted a non-small volume cancer (OR, 7.52). CONCLUSIONS: Unilateral or unifocal cancer on biopsy are among the strongest predictors of unilateral, unifocal, and small volume prostate cancer in contemporary practice.
机译:目的:当代前列腺癌通常体积小,早期。通过微创疗法(例如冷冻疗法)进行小计腺体切除术需要术前预测单灶,单侧,切缘阴性和小体积(小于0.5 mL)癌症。方法:我们检查了匹配的活检和前列腺切除术,以及从2000年至2003年在两家机构接受手术的393例患者的临床数据。根治性前列腺切除术标本以5毫米的间隔均匀切片并完全包埋。通过回归分析将许多临床和活检变量与前列腺切除术标本中的单灶,单侧,切缘阴性和0.5 mL或更少体积的癌症相关联。确定赔率(OR)。结果:在前列腺切除术中,有92例(23%)患有单灶癌,90例(23%)患有单侧癌,348例(89%)患有器官受限癌,106例(31%)患有小体积癌。在活检中单侧癌病例中有71%至76%发生了单侧癌(OR为4.30;如果取样了9个或更多的核心,则OR上升到6.83),并通过活检的单活性进行了预测(OR为2.63)。单灶癌是通过活检中的单侧(OR,2.66)而非单灶癌预测的。通过活检中的单侧癌(OR,2.53;阳性预测值,82%)和血清前列腺特异性抗原(OR,5.33)预测手术切缘阴性。在活检中,单侧(OR,5.50)和单灶(OR,7.98)癌预测为小体积癌;格里森评分大于7则预示着非小体积癌症(OR为7.52)。结论:活检中的单侧或单灶癌是当代实践中单侧,单灶和小体积前列腺癌的最强预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号